# 13th International Cancer and Medical Oncology Conference & Exhibition
## CancerUCG

> CancerUCG

- **Dates:** 2027-02-01 – 2027-02-02
- **Location:** Novotel Al Barsha, DUBAI, UAE
- **Format:** Hybrid
- **CME credits:** 30 CME/CPD Credits by The ACCME
- **Organizer:** Utilitarian Conferences Gathering
- **Website:** https://cancer.ucgconferences.com/

## About

Advancing Cancer Research, Diagnostics, and Precision Oncology

## Registration

Register online: https://cancer.ucgconferences.com/register

- Abstract/Presentation/Poster Review Fee — USD 30
- Abstract Publication — USD 100
- Abstract/Presentation/Poster Review Fee — USD 60
- Speaker/Poster 1 Day Entry — USD 150
- Paper Publication — USD 300
- Speaker/Poster Package — USD 299
- Speaker/Poster 1 Day Entry — USD 400
- Speaker/Poster Package — USD 700
- Delegate/Listener 1 Day Entry — USD 125
- Delegate/Listener Package — USD 249
- 30 CME/CPD Credits — USD 250
- Certificate(Mandatory) — USD 30
- Package A(30 CME Credits) — USD 899
- Package B(30 CME Credits) — USD 1099
- Student Fee (ID card required) — USD 125
- Visa Invitation Letter — USD 50
- Delegate/Listener 1 Day Entry — USD 350
- Delegate/Listener Package — USD 600
- Group Pass(3 Attendees) — USD 1500
- 30 CME/CPD Credits — USD 600

## Speakers

- [Dr. Abdulaziz Alomiery](https://cancer.ucgconferences.com/speakers/691-dr-abdulaziz-alomiery) — Assistant Professor at the Basic Science Department, King Saud University
- [Dr. Advait Ajit Karmarkar](https://cancer.ucgconferences.com/speakers/653-dr-advait-ajit-karmarkar) — First Year Resident, Dept of Pathology, Dr DY Patil Medical College
- [Dr. Ahmed Yehia Sharab](https://cancer.ucgconferences.com/speakers/672-dr-ahmed-yehia-sharab) — Distinguished Physician, Co-Founder and CEO, HCMA AI
- [Dr. Aisha Memon](https://cancer.ucgconferences.com/speakers/676-dr-aisha-memon) — Assistant Professor and a Consultant Histopathologist, Aga Khan University Hospital, Karachi, Pakistan
- [Dr. Aishwarya Thakurdesai](https://cancer.ucgconferences.com/speakers/142-dr-aishwarya-thakurdesai) — MBBS from Seth G. S. Medical College in Mumbai, Garnered Several Awards and Honors, Including the 2024 AASLD Foundation Emerging Liver Scholar Award
- [Dr. Akanksha Anu](https://cancer.ucgconferences.com/speakers/1028-dr-akanksha-anu) — Advances in Thyroid Pathology
- [Dr. Akanksha Pandey](https://cancer.ucgconferences.com/speakers/521-dr-akanksha-pandey) — Department of Pathology, Heritage Institute of Medical Sciences, Varanasi
- [Dr. Aliyarbayova Aygun Aliyar](https://cancer.ucgconferences.com/speakers/537-dr-aliyarbayova-aygun-aliyar) — Assistant professor of Department of Cytology, embryology and Histology, Azerbaijan Medical University
- [Dr. Ashwini Malla](https://cancer.ucgconferences.com/speakers/1021-dr-ashwini-malla) — Assistant Professor, PSG College of Arts and Science
- [Dr. Babatope Lanre Awosusi](https://cancer.ucgconferences.com/speakers/607-dr-babatope-lanre-awosusi) — Head of the Histopathology Department, King Khalid General Hospital, Al Majmaah
- [Dr. Bangkang Fu](https://cancer.ucgconferences.com/speakers/1019-dr-bangkang-fu) — Research primarily focuses on cardiovascular, neurological, and oncological imaging, Guizhou University
- [Dr. Batool Ahmad](https://cancer.ucgconferences.com/speakers/603-dr-batool-ahmad) — Pathology Resident, LN Medical College and J.K. Hospital
- [Dr. Emil Salmo](https://cancer.ucgconferences.com/speakers/592-dr-emil-salmo) — Consultant Pathologist, Department of Histopathology, The Royal Oldham Hopspita
- [Dr. Eshraq El Masry](https://cancer.ucgconferences.com/speakers/615-dr-eshraq-el-masry) — DHA-licensed Clinical Oncologist and General Practitioner based in the UAE
- [Dr. Esraa Aldujaily](https://cancer.ucgconferences.com/speakers/633-dr-esraa-aldujaily) — Head of the Department of Pathology and Forensic Medicine, University of Kufa/ Faculty of Medicine
- [Dr. Folinas Konstantinos](https://cancer.ucgconferences.com/speakers/449-dr-folinas-konstantinos) — Consultant Medical Oncologist, Oncology Department of 251 Airforce General Hospital
- [Dr. Gurbanova Shahana Gazanfar](https://cancer.ucgconferences.com/speakers/540-dr-gurbanova-shahana-gazanfar) — Assistant of Department of Cytology, Embryology and Histology, Azerbaijan Medical University
- [Dr. Hadassah Sade](https://cancer.ucgconferences.com/speakers/588-dr-hadassah-sade) — Managing Director at AstraZeneca Computational Pathology, AstraZeneca
- [Dr. Iskander Chaudhry](https://cancer.ucgconferences.com/speakers/595-dr-iskander-chaudhry) — Consultant Pathologist, Royal Blackburn Teaching Hospital
- [Dr. Jose Manuel Cervera-Grau](https://cancer.ucgconferences.com/speakers/451-dr-jose-manuel-cervera-grau) — Medical Oncology (18ys) INCLIVA in Spain, International Cancer Care Society
- [Dr. Juliana Bicca](https://cancer.ucgconferences.com/speakers/63-dr-juliana-bicca) — Speaker, Vice-President of the Brazilian Academy of Functional and Integrative Medicine
- [Dr. Khalid Al-Baimani](https://cancer.ucgconferences.com/speakers/622-dr-khalid-al-baimani) — Medical Oncologist
- [Dr. Khan Ummiya Afreen](https://cancer.ucgconferences.com/speakers/1029-dr-khan-ummiya-afreen) — Department of Pathology, Kamineni Academy Of Medical Sciences And Research Center
- [Dr. Leon Wreyford](https://cancer.ucgconferences.com/speakers/450-dr-leon-wreyford) — Oncologist Communication / Health Professional, University of Southern Queensland
- [Dr. Maria Putova](https://cancer.ucgconferences.com/speakers/1033-dr-maria-putova) — Biologist-Researcher in Clinical Laboratory Diagnostics, Moscow Clinical Scientific Center
- [Dr. Matus Coma](https://cancer.ucgconferences.com/speakers/448-dr-matus-coma) — Leading scientist at the Department of Pharmacology, Medical Faculty, Pavol Jozef Safarik University
- [Dr Meg Rynderman OAM](https://cancer.ucgconferences.com/speakers/1022-dr-meg-rynderman-oam) — Australian Cancer Survivorship Centre at Peter, Consumer Advocate - Australian Cancer Survivorship Centre at Peter MacCallum Cancer Centre
- [Dr. Mehrdad Mohammadi](https://cancer.ucgconferences.com/speakers/646-dr-mehrdad-mohammadi) — Assistant Professor SUMS and chief executive officer, Smart Medical Centre
- [Dr. Nada Shamina](https://cancer.ucgconferences.com/speakers/695-dr-nada-shamina) — Chemical Pathologist in the UK
- [Dr. Nariman Nawar](https://cancer.ucgconferences.com/speakers/118-dr-nariman-nawar) — Pathologyist, West Virginia University | WVU · Department of Pathology MD
- [Dr. Neha Kamble](https://cancer.ucgconferences.com/speakers/656-dr-neha-kamble) — Assistant Professor, Dr DY Patil Medical College, Hospital and Research Centre, Pune, Dr. D.Y. Patil Medical College
- [Dr Neha Patel](https://cancer.ucgconferences.com/speakers/1023-dr-neha-patel) — CONSULTANT RADIATION ONCOLOGIST, ADDITIONAL MEDICAL DIRECTOR
- [Dr. Noskova Karina](https://cancer.ucgconferences.com/speakers/1035-dr-noskova-karina) — Head of the Laboratory, Moscow Clinical Scientific Center
- [Dr. Pradeep Kumar Kar](https://cancer.ucgconferences.com/speakers/630-dr-pradeep-kumar-kar) — Kidwai Memorial Institute of Oncology, Fortis Cancer Institute and Farcast Biosciences
- [Dr. Samira Yagubova](https://cancer.ucgconferences.com/speakers/601-dr-samira-yagubova) — Associate professor, Department of Pathology, Azerbaijan Medical University
- [Dr Sanya Arora](https://cancer.ucgconferences.com/speakers/452-dr-sanya-arora) — Oncology Fellow, The London Clinic,, Clinical research fellow, ULCH,
- [Dr. Shahla Masood](https://cancer.ucgconferences.com/speakers/457-dr-shahla-masood) — Professor and Chair, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jacksonville
- [Dr. Shraddha Krupa](https://cancer.ucgconferences.com/speakers/635-dr-shraddha-krupa) — Pathology Resident
- [Dr. Silky Rai](https://cancer.ucgconferences.com/speakers/627-dr-silky-rai) — Department of Oncopathology, Mahamana Pandit Madan Mohan Malviya Cancer Centre
- [Dr. Sviatoslav Zinovev](https://cancer.ucgconferences.com/speakers/1020-dr-sviatoslav-zinovev) — Oncologist, Nizhny Novgorod Research Institute of Oncology
- [Dr. Syeda Ayesha Fatima](https://cancer.ucgconferences.com/speakers/455-dr-syeda-ayesha-fatima) — Assistant Professor, Department of Pharmacology, Sulaiman Al Rajhi University
- [Dr. Tadeja Skok](https://cancer.ucgconferences.com/speakers/1026-dr-tadeja-skok) — Breast Cancer, Imaging Characteristics in Breast Cancer
- [Dr. Voropaeva Yana](https://cancer.ucgconferences.com/speakers/1031-dr-voropaeva-yana) — Physician of Clinical laboratory diagnostics, Moscow Clinical Scientific Center
- [Dr. Wardah Fatima](https://cancer.ucgconferences.com/speakers/1036-dr-wardah-fatima) — Oral Pathology resident at Ziauddin University, Karachi, Can Saliva Replace Tissue? The Role of Liquid Biopsy and AI in Oral Oncology
- [Dr. Weam Mohamed Ahmed Eltoum](https://cancer.ucgconferences.com/speakers/613-dr-weam-mohamed-ahmed-eltoum) — Consultant Histopathologist, Stockport NHS Foundation Trust
- [Eléonore DJIKEUSSI](https://cancer.ucgconferences.com/speakers/458-el-onore-djikeussi) — Founder, Oncologist–Hematologist & Nutrition Expert, NutriGnosis SA
- [Mr. Alexandre Mendes](https://cancer.ucgconferences.com/speakers/1027-mr-alexandre-mendes) — Cardio-Oncology &amp; Patient Safety
- [Mr. Omar Ali](https://cancer.ucgconferences.com/speakers/467-mr-omar-ali) — Former NICE adviser and head of payers at Verpora
- [Mr. Salam Musa](https://cancer.ucgconferences.com/speakers/1025-mr-salam-musa) — Consultant Oncoplastic breast surgeon, Presentation Focus: Impact of Breast Surgery on Patients
- [Mrs. Uta Rouse Bsc](https://cancer.ucgconferences.com/speakers/453-mrs-uta-rouse-bsc) — VE-comedus UG™, Hospizinitiative Rostock e.V.
- [Ms. Ginny Dent Brant](https://cancer.ucgconferences.com/speakers/1024-ms-ginny-dent-brant) — Cancer Survivor, Holistic Healing Approaches &amp;amp;amp; Cancer Survivorship
- [Ms. Rania Mohamad Othman](https://cancer.ucgconferences.com/speakers/160-ms-rania-mohamad-othman), Al-Sham Private University
- [Prof. Nadia Sam](https://cancer.ucgconferences.com/speakers/135-prof-nadia-sam) — Laboratory of language, University of Blida2 Lounici-Algeria

## Tracks

- **Track 1-Cancer**: **[Cancer](https://cancer.ucgconferences.com/submit-abstract)** is a complex group of diseases marked by the uncontrolled growth of abnormal cells, which can invade nearby tissues and spread to distan
- **Track 2: Medical Oncology**: **[Medical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field focused on the prevention, diagnosis, and treatment of cancer through systemic therapies such as chemot
- **Track 3:Immunotherapy**: **[Immunotherapy](https://cancer.ucgconferences.com/submit-abstract)** is an innovative approach to cancer treatment that harnesses and strengthens the body’s immune system to recognize and fight canc
- **Track 4: Radiotherapy**: **[Radiotherapy](https://cancer.ucgconferences.com/submit-abstract)**, also known as radiation therapy, is a widely used cancer treatment that employs high-energy radiation to destroy cancer cells or 
- **Track 5: Chemotherapy**: **[Chemotherapy](https://cancer.ucgconferences.com/submit-abstract)** is a widely used cancer treatment that employs powerful drugs to destroy cancer cells or slow their growth and division. Because t
- **Track 6: Surgical Oncology**: **[Surgical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field of medicine focused on the surgical diagnosis, staging, and treatment of cancer. Surgical oncologists 
- **Track 7: Hormone-therapy**: **[Hormone Therapy](https://cancer.ucgconferences.com/submit-abstract)** is a treatment approach that uses hormones or hormone-blocking medications to manage hormone-related conditions and diseases. I
- **Track 8: Leukemia**: **[Leukemia](https://cancer.ucgconferences.com/submit-abstract)** is a type of cancer that affects the blood and bone marrow, which is the soft, spongy tissue inside bones where blood cells are produc
- **Track 9: Cancer Genetics**: ** [Cancer genetics](https://cancer.ucgconferences.com/submit-abstract)** is the study of genetic mutations and alterations that drive the initiation, progression, and metastasis of cancer. It focuses
- **Track 10: Cancer Epigenetics**: **[Cancer Epigenetics](https://cancer.ucgconferences.com/submit-abstract)** explores heritable changes in gene expression that occur without altering the underlying DNA sequence. These epigenetic chan
- **Track 11: Tumor Microenvironment**: The **[Tumor Microenvironment](https://cancer.ucgconferences.com/submit-abstract)** (TME) is the complex and dynamic environment surrounding a tumor, consisting of immune cells, stromal cells, blood v
- **Track 12: Cancer Metastasis**: **[Cancer metastasis](https://cancer.ucgconferences.com/submit-abstract)** is the complex process through which cancer cells detach from the primary tumor, invade surrounding tissues, and spread to di
- **Track 13: Breast cancer**: **[Breast cancer](https://cancer.ucgconferences.com/submit-abstract)** is a major form of cancer that develops when abnormal cells in the breast tissue grow and divide uncontrollably, potentially form
- **Track 14: Lung Cancer**: **[Lung cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that originates in the tissues of the lungs and is characterized by the uncontrolled growth of abnormal cel
- **Track 15: Colorectal Cancer**: **[Colorectal cancer](https://cancer.ucgconferences.com/submit-abstract)** is a common malignancy that develops in the colon or rectum, which are integral parts of the digestive system. It often begin
- **Track 16: Prostate Cancer**: **[Prostate cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that originates in the prostate gland, a small gland in the male reproductive system that contributes to the pr
- **Track 17: Skin Cancer**: **[Skin cancer](https://cancer.ucgconferences.com/submit-abstract)** is a group of malignancies characterized by the uncontrolled growth of abnormal cells in the skin. Prolonged exposure to ultraviole
- **Track 18: Blood Cancer**: **[Blood cancer](https://cancer.ucgconferences.com/submit-abstract)**, or hematologic malignancy, affects the blood, bone marrow, and lymphatic system, causing abnormal production and function of bloo
- **Track 19: Brain Tumor**: **[Brain tumors](https://cancer.ucgconferences.com/submit-abstract)** are abnormal growths that develop in the brain or central nervous system. This track highlights advances in neuro-oncology, diagno
- **Track 20: Ovarian Cancer**: **[Ovarian cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the ovaries, which are part of the female reproductive system and produce eggs and hormones suc
- **Track 21: Head and Neck Cancer**: **[Head and neck cancer](https://cancer.ucgconferences.com/submit-abstract)** includes malignancies affecting the mouth, throat, larynx, nasal cavity, sinuses, and salivary glands. Most cases arise fr
- **Track 22: Pancreatic Cancer**: **[Pancreatic cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that often presents at an advanced stage, making early diagnosis and treatment challenging. This trac
- **Track 23: Liver cancer**: **[Liver cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the liver and can significantly affect its essential functions, including metabolism, detoxificat
- **Track 24: Bone Cancer**: **[Bone cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops from abnormal cells within bone tissue and can form tumors that invade surrounding structures or spre
- **Track 25:Cancer Stem Cells**: **[Cancer stem cells](https://cancer.ucgconferences.com/submit-abstract)** (CSCs) are a specialized population of tumor cells with self-renewal and differentiation capabilities. They are thought to co
- **Track 26:Cancer Biomarkers**: **[Cancer biomarkers](https://cancer.ucgconferences.com/submit-abstract)** are measurable biological indicators found in blood, tissues, or other body fluids that can provide valuable information abou
- **Track 27: Precision Oncology**: **[Precision oncology](https://cancer.ucgconferences.com/submit-abstract)** is an individualized approach to cancer care that uses genomic sequencing, molecular profiling, and biomarker analysis to id
- **Track 28: Cancer Prevention**: **[Cancer prevention](https://cancer.ucgconferences.com/submit-abstract)** focuses on reducing the risk of cancer through proactive strategies that address modifiable risk factors, promote healthy beh
- **Track 29:Cancer Epidemiology**: **[Cancer epidemiology](https://cancer.ucgconferences.com/submit-abstract)** examines the distribution, causes, risk factors, trends, and outcomes of cancer across populations. This track focuses on c
- **Track 30:Cancer Screening**: **[Cancer screening](https://cancer.ucgconferences.com/submit-abstract)** involves the early identification of cancer or precancerous conditions in individuals who may not yet have symptoms. This trac

## Programme

- Mon 1 Feb 2027 — 08:00–08:30 — Registration Desk
- Tue 2 Feb 2027 — 08:00–08:30 — Registration Desk
- Tue 2 Feb 2027 — 08:30–09:00 — Opening Ceremony
- Mon 1 Feb 2027 — 08:30–09:00 — Opening Ceremony
- Tue 2 Feb 2027 — 09:00–10:00 — Keynote Introduction & Speech
- Mon 1 Feb 2027 — 09:00–10:00 — Keynote Introduction & Speech
- Tue 2 Feb 2027 — 10:00–10:30 — Speech & Poster Presentation
- Mon 1 Feb 2027 — 10:00–10:30 — Speech & Poster Presentation
- Tue 2 Feb 2027 — 10:30–10:45 — Coffee Break and Networking
- Mon 1 Feb 2027 — 10:30–10:45 — Coffee Break and Networking
- Mon 1 Feb 2027 — 10:45–11:30 — Exhibit Hall Open
- Tue 2 Feb 2027 — 10:45–11:30 — Exhibit Hall Open
- Tue 2 Feb 2027 — 11:30–13:00 — Speaker & Poster Presentations
- Mon 1 Feb 2027 — 11:30–13:00 — Speaker & Poster Presentations
- Tue 2 Feb 2027 — 13:00–13:10 — Professional Photography
- Mon 1 Feb 2027 — 13:00–13:10 — Professional Photography
- Tue 2 Feb 2027 — 13:10–14:00 — Lunch Break & Networking
- Mon 1 Feb 2027 — 13:10–14:00 — Lunch Break & Networking
- Tue 2 Feb 2027 — 16:00–16:15 — Coffee Break & Networking
- Tue 2 Feb 2027 — 16:15–17:00 — Speech & Poster Presentation
- Tue 2 Feb 2027 — 14:00–16:00 — Speaker & Poster Presentations
- Tue 2 Feb 2027 — 17:00–17:30 — Panel Discussion
- Mon 1 Feb 2027 — 14:00–16:00 — Speaker & Poster Presentations
- Tue 2 Feb 2027 — 17:30–17:45 — Certificate Distribution
- Mon 1 Feb 2027 — 16:00–16:15 — Coffee Break & Networking
- Mon 1 Feb 2027 — 16:15–17:00 — Speech & Poster Presentation
- Mon 1 Feb 2027 — 17:00–17:30 — Panel Discussion
- Tue 2 Feb 2027 — 17:45–18:00 — Professional Photography
- Mon 1 Feb 2027 — 17:30–17:45 — Certificate Distribution
- Mon 1 Feb 2027 — 17:45–18:00 — Professional Photography
- Tue 2 Feb 2027 — 18:00–18:30 — Closing Remarks
- Mon 1 Feb 2027 — 18:00–18:30 — Closing Remarks

## Submit an abstract

Submit at https://cancer.ucgconferences.com/submit-abstract (deadline 2026-08-31).

## Key pages

- [Home](https://cancer.ucgconferences.com/)
- [Speakers](https://cancer.ucgconferences.com/speakers)
- [Agenda & programme](https://cancer.ucgconferences.com/agenda)
- [Tracks](https://cancer.ucgconferences.com/tracks)
- [Register](https://cancer.ucgconferences.com/register)
- [Submit an abstract](https://cancer.ucgconferences.com/submit-abstract)
- [Sitemap](https://cancer.ucgconferences.com/sitemap.xml)
- Conference API: https://cancer.ucgconferences.com/api/events/13th-international-cancer-and--hgqv

## For AI agents & platforms

- OpenAPI spec: https://cancer.ucgconferences.com/api/openapi.json
- MCP server (JSON-RPC over POST): https://cancer.ucgconferences.com/api/mcp
- ChatGPT plugin manifest: https://cancer.ucgconferences.com/.well-known/ai-plugin.json

### Key endpoints

- List/search conferences: GET https://cancer.ucgconferences.com/api/events?q=&category=&country=&limit=
- Conference detail: GET https://cancer.ucgconferences.com/api/events/{code}
- Submit abstract (Bearer auth or guest): POST https://cancer.ucgconferences.com/api/abstracts
- Start registration (Bearer auth or guest): POST https://cancer.ucgconferences.com/api/checkout/session
- Embeddable conference card: https://cancer.ucgconferences.com/embed/event/{code}

Write actions accept a Bearer token (a user session id from POST /api/auth/login).
